Dr. Macklis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3951Fax+1 216-286-3989
Education & Training
- Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1984 - 1987
- Dana-Farber Cancer InstitutePost-Doctoral Fellowship, 1985 - 1986
- Brigham and Women's HospitalInternship, Internal Medicine, 1983 - 1984
- Harvard Medical SchoolClass of 1982
- Yale UniversityBS, Molecular Biophysics, summa cum laude, 1978
- Yale UniversityMS, Molecular Biophysics, summa cum laude, 1978
- Yale UniversityB.S., Molecular Biophysics, Summa Cum Laude, 1978
- Yale UniversityM.S., Molecular Biophysics, Summa Cum Laude, 1978
Certifications & Licensure
- OH State Medical License 1993 - 2026
- NY State Medical License 2001 - 2023
- CA State Medical License 2003 - 2021
- KY State Medical License 2017 - 2021
- MN State Medical License 2014 - 2020
- MI State Medical License 2001 - 2018
- MA State Medical License 1984 - 2012
- American Board of Radiology Radiation Oncology
- Join now to see all
Awards, Honors, & Recognition
- Best Doctors in America 1998
- Who’s Who in the World 1998
- Who's Who in America 1998
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation Start of enrollment: 2005 Dec 01
- External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 Dec 01
- A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- 45 citationsE2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma.M. E. Crosby, James W. Jacobberger, Damodar Gupta, Roger M. Macklis, Alexandru Almasan
Oncogene. 2007-03-22 - 51 citationsRadiation therapy in pregnancy: risk calculation and risk minimization.J F Jr Greskovich, Roger M. Macklis
Seminars in Oncology. 2000-12-01 - 26 citationsSynthesis of hemoglobin F in adult simian erythroid progenitor-derived colonies.Roger M. Macklis, Jamshid Javid, Jeffrey M. Lipton, Michele Kudisch, Penelope K. Pettis
The Journal of Clinical Investigation. 1982-10-01
Journal Articles
- Radium-223 in the Treatment of Osteoblastic Metastases: A Criticial Clinical ReviewHumm JL. Sartor O. Parker C. Bruland O. and Macklis RM, Int.J Rad. Onc.Biol.Phys, 1/1/2015
- Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: Treatment outcomes in extranodal marginal zone subtypeCraig A. Portell, Mary E. Aronow, Lisa A. Rybicki, Roger Macklis, Arun D. Singh, John W. Sweetenham, Clinical Lymphoma Myeloma and Leukemia, 1/1/2013
- An Overview of ‘Accountable Care Organizations’ For Oncology SpecialistsAnish J Mehta, Roger Macklis, J. Onc Practice, 1/1/2013
- Join now to see all
Books/Book Chapters
Lectures
- Alpha Particle Radiobiology for Radium-223 (“Alpharadin”): The Fortuitous “Goldilocks” Effect Observed For Hormone-Resistant Metastatic Prostate Cancer1/1/2012
- Long Term Outcomes of Radiation Therapy1/1/2012
- Radiotherapy and Lymphoma: Evolving Role1/1/2011
- Join now to see all
Other
- RIT for Non-Hodgkin’s Lymphoma: Taking the Team ApproachThakkar VV, Mackis R, ADVANCE for Imaging and Oncology Administrators
1/1/2005 - Getting on BoardMahadevan A, Macklis RM, Videtic GV, et al, ADVANCE for Imaaging and Oncology Administrators
1/1/2003 - Feasibility of human/robot cooperation in image-directed radiation oncologyAmeduri SA, Newman WS, Weinhous MS, Glosser GD, Macklis RM, Society Photo-Optical Instrumentation Engineers (SPIE) Int’l Technical Group Newsletter
1/1/1999 - Join now to see all
Grant Support
- Animal Models In Immunochelate RadiotherapyNational Cancer Institute1989–1993
Professional Memberships
- Member
Industry Relationships
- Extensive tech transfer and translational science effort leadership, Multiple organizations collaborating with multiple commercial partners
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: